Dr. Ned Braunstein, M.D. Internal Medicine - Rheumatology Medicare: Not Enrolled in Medicare Practice Location: 777 Old Saw Mill River Rd, Regeneron Pharmaceuticals, Tarrytown, NY 10591 Phone: 914-847-3099 Fax: 914-847-7688 |
News Archive
It's easy to think about the initial purchase price as the main cost of a mattress…which it is…to start with. But, you don't just have a mattress for a short period. If you're investing in a dynamic mattress, also known as an airflow mattress, then you want to be able to use this for a prolonged period.
Neovasc Inc., a developer of novel technologies used to treat vascular disease, today announced that the first patients have been enrolled in its COSIRA trial designed to assess the clinical efficacy of the Neovasc Reducer(TM) product for the treatment of refractory angina. The COSIRA (Coronary Sinus Reducer for Treatment of Refractory Angina) trial is a multicenter, sham-controlled, randomized, double-blinded study of the Reducer that is expected to enroll up to 124 patients.
Avita Medical Ltd., a regenerative medicine company specializing in the treatment of wounds and skin defects, today announced that statistically significant data from a randomized controlled study demonstrated that its single-use autologous cell suspension technology ReCell was safe and effective in skin repigmentation for patients suffering with depigmented skin lesions caused by vitiligo and piebaldism.
Among patients undergoing incisional hernia repair, the use of mesh to reinforce the repair was associated with a lower risk of hernia recurrence over 5 years compared with when mesh was not used, although with long-term follow-up, the benefits attributable to mesh were offset in part by mesh-related complications, according to a study published online by JAMA.
› Verified 8 days ago